International Business News - AMLN http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Shares of Amylin Pharmaceuticals Inc. fell Thursday, as investors remained concerned about the company's third-quarter sales for the diabetes treatment Byetta and regulatory timeline for an extended-release version of the drug. http://www.ibtimes.com/articles/20081009/amylin-continues-slide-on-diabetes-drug-concerns.htm Thu, 09 Oct 2008 13:36:39 EDT Biotechnology stocks managed to gain ground during a highly volatile third quarter as potential blockbuster drugs and multibillion-dollar buyout bids gave the largest players a steady footing on top of tumbling markets. http://www.ibtimes.com/articles/20080930/sector-snap-biotechnology.htm Tue, 30 Sep 2008 17:08:16 EDT Big pharmaceutical companies and their biotech cousins will likely weather the financial crisis engulfing Wall Street, several analysts said, because of the necessity of their products and cash-rich balance sheets. http://www.ibtimes.com/articles/20080923/sector-snap-drug-developers-insulated-from-storm.htm Tue, 23 Sep 2008 14:28:34 EDT Shares of biotechnology companies continued following the broader market's wide sways Monday after a week of heightened concern over the health and future of Wall Street and nation's financial system. http://www.ibtimes.com/articles/20080922/sector-snap-biotechnology-share-decline.htm Mon, 22 Sep 2008 13:38:23 EDT Among the stock activity stories for Monday, Sept. 15, from AP Financial News: HOUSTON (AP)--Shares of Transocean Inc., the world's largest offshore drilling contractor, slipped Monday as planes crisscrossed the Gulf of Mexico assessing damage to deep-water facilities. http://www.ibtimes.com/articles/20080915/movers-roundup-transocean-wachovia.htm Mon, 15 Sep 2008 14:27:35 EDT Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market: NYSE http://www.ibtimes.com/articles/20080915/take-two-panera-bread-wendys-among-big-movers.htm Mon, 15 Sep 2008 16:39:03 EDT Shares of biotechnology company Amylin Pharmaceuticals Inc. jumped Monday following billionaire investor Carl Icahn's move to increase his ownership stake to 7.3 percent. http://www.ibtimes.com/articles/20080915/amylin-shares-rise-as-icahn-boosts-ownership-stake.htm Mon, 15 Sep 2008 18:49:48 EDT Billionaire investor Carl Icahn increased his stake in Amylin Pharmaceuticals Inc. to 7.3 percent, according to a filing with the Securities and Exchange Commission Friday. http://www.ibtimes.com/articles/20080915/carl-icahn-boosts-stake-in-amylin-pharmaceuticals.htm Mon, 15 Sep 2008 07:27:15 EDT Shares of several diabetes drug developers received a slight boost Tuesday as companies including Eli Lilly & Co. and Merck & Co. touted the effectiveness of their respective treatments in an already highly competitive market. http://www.ibtimes.com/articles/20080909/sector-snap-diabetes-drug-developers.htm Tue, 09 Sep 2008 11:46:42 EDT Amylin Pharmaceuticals Inc. and Eli Lilly & Co. said Tuesday their diabetes drug Byetta worked better at reducing blood-sugar levels following a meal compared with Merck & Co.'s Januvia. http://www.ibtimes.com/articles/20080909/amylin-elli-lilly-tout-diabetes-drug-over-merck.htm Tue, 09 Sep 2008 10:55:39 EDT Among the stock activity stories for Friday, Sept. 5, from AP Financial News: ATLANTA (AP)--Shares of BlueLinx Holdings Inc., a distributor of building products, dropped Friday as an analyst downgraded the company's stock following a recent run-up in share price. http://www.ibtimes.com/articles/20080905/movers-roundup-bluelinx-amylin-pharma.htm Fri, 05 Sep 2008 18:20:10 EDT Shares of Amylin Pharmaceuticals Inc. fell Friday after an analyst suggested Amylin's diabetes drug Byetta is more likely to cause pancreatitis than a rival treatment, Merck & Co.'s Januvia. http://www.ibtimes.com/articles/20080905/amylin-falls-as-analyst-voices-byetta-concerns.htm Fri, 05 Sep 2008 16:58:38 EDT Among the stock activity stories for Thursday, Aug. 28, from AP Financial News: PITTSBURGH (AP)--Shares of Caterpillar Inc. rose Thursday after the company's top executive said the heavy equipment maker expects record sales this year, driven by booming demand in China and other emerging economies. http://www.ibtimes.com/articles/20080828/movers-roundup-caterpillar-dillards.htm Thu, 28 Aug 2008 14:48:46 EDT Stocks that moved substantially or traded heavily Thursday on the New York Stock Exchange and Nasdaq Stock Market: NYSE http://www.ibtimes.com/articles/20080828/mbia-tiffany-ual-williams-sonoma-are-big-movers.htm Thu, 28 Aug 2008 16:41:20 EDT Shares of Amylin Pharmaceuticals Inc. staged a slight recovery Thursday after falling sharply the day before, when Amlyin and its partner Eli Lilly & Co. reported new deaths among patients taking their diabetes treatment Byetta. http://www.ibtimes.com/articles/20080828/amylin-shares-recover-slightly-after-byetta-deaths.htm Thu, 28 Aug 2008 17:29:56 EDT Among the sector activity stories for Wednesday, Aug. 27, from AP Financial News: NEW YORK (AP)--Eli Lilly & Co. and Amylin Pharmaceuticals Inc. could feel more competitive pressure in the diabetes market as their drug Byetta comes under scrutiny after new patient deaths were reported Tuesday. http://www.ibtimes.com/articles/20080827/sector-roundup-diabetes-drugs-auto-suppliers.htm Wed, 27 Aug 2008 14:16:04 EDT Shares of Alkermes Inc. declined Wednesday as investors weighed potential bad news for one drug Alkermes helped develop with good news for another. Alkermes helped develop the long-acting formula in Exenatide LAR, a diabetes drug that Eli Lilly and Co. and Amylin Pharmaceuticals are hoping to launch in 2009. It also helped develop the schizophrenia drug Risperdal Consta with Johnson & Johnson. http://www.ibtimes.com/articles/20080827/alkermes-slides-on-diabetes-drug-concerns.htm Wed, 27 Aug 2008 17:24:13 EDT Eli Lilly & Co. and Amylin Pharmaceuticals Inc. could feel more competitive pressure in the diabetes market as their drug Byetta comes under scrutiny after new patient deaths were reported Tuesday. http://www.ibtimes.com/articles/20080827/sector-snap-diabetes-drug-treatments.htm Wed, 27 Aug 2008 12:02:23 EDT Among the premarket stories for Wednesday, Aug. 27, from AP Financial News: NEW YORK (AP)--Shares of Amylin Pharmaceuticals Inc. dropped in premarket trading Wednesday after the drug developer and its partner Eli Lilly & Co. reported four new deaths of patients who had taken their diabetes drug Byetta. http://www.ibtimes.com/articles/20080827/premarket-roundup-amylin-pharma-j-crew.htm Wed, 27 Aug 2008 09:46:02 EDT Shares of Amylin Pharmaceuticals Inc. dropped in premarket trading Wednesday after the drug developer and its partner Eli Lilly & Co. reported four new deaths of patients who had taken their diabetes drug Byetta. http://www.ibtimes.com/articles/20080827/ahead-of-the-bell-amylin-drops-on-byetta-deaths.htm Wed, 27 Aug 2008 09:08:22 EDT